Earlier in the week, Aurora Cannabis Inc. (ACB.TO) announced that it is expanding the size of a marijuana production facility currently under construction in Medicine Hat, Alta, by 33 percent.
Through a release published on Wednesday, 10th March, The Edmonton-based pot producer said that as it aims to ramp up production as there is an increase in the global demand for medical cannabis, it is increasing its high-tech Aurora Sun facility from an original plan of 1.2 million square feet to 1.62 million square feet.
According to Aurora, it expects the Medicine Hat facility to produce well over 230,000 kilograms of cannabis yearly.
In a press release, Terry Booth, the CEO of Aurora said, “The increased scale of Aurora Sun reflects our expectations for the long-term growth in global demand, particularly the higher margin international medical markets which will be faced with notable supply shortages for the conceivable future.”
Aurora CEO further added, “Sun is also designed with flexibility in mind to enable us to quickly meet changing market demands, particularly as breeding and cultivation technologies evolve and as customer preferences and requirements change.”
As per reports, the first time the company announced the acquisition of land to build the Sun facility was back in April 2018, when it also predicted that it will complete the project by the first quarter of 2019.
Through a press release issued on Wednesday, March 10th, Aurora said that it has almost finished with operations for the groundwork, and its steel structure is being erected as glass at the Sun facility is slated for installation in the month of May.
According to GMP Securities analyst Martin Landry, Aurora Sun could transform into one of the largest production facilities in Canada and possibly all over the world too, thanks to the facility’s expansion.
In a note issued to clients on Wednesday, March 10th, “Large scale facilities like Aurora Sun are a differentiation factor for [Aurora] and could provide supply chain benefits.”
Landry also further highlighted that the upgraded facility will be built as per EU Good Manufacturing Practice standards, through which Aurora’s cannabis can be legally sold in the European medical markets.